These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1523237)

  • 1. The effects of amphetamine on body weight and energy expenditure.
    Jones JR; Caul WF; Hill JO
    Physiol Behav; 1992 Mar; 51(3):607-11. PubMed ID: 1523237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphetamine's effects on food consumption and body weight: the role of adaptive processes.
    Caul WF; Jones JR; Barrett RJ
    Behav Neurosci; 1988 Jun; 102(3):441-50. PubMed ID: 3395454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of amphetamine on food intake and weight: timing of injections and food access.
    Jones JR; Caul WF
    Physiol Behav; 1992 Sep; 52(3):515-20. PubMed ID: 1409914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic central infusion of cocaine- and amphetamine-regulated transcript (CART 55-102): effects on body weight homeostasis in lean and high-fat-fed obese rats.
    Rohner-Jeanrenaud F; Craft LS; Bridwell J; Suter TM; Tinsley FC; Smiley DL; Burkhart DR; Statnick MA; Heiman ML; Ravussin E; Caro JF
    Int J Obes Relat Metab Disord; 2002 Feb; 26(2):143-9. PubMed ID: 11850744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher Daily Energy Expenditure and Respiratory Quotient, Rather Than Fat-Free Mass, Independently Determine Greater ad Libitum Overeating.
    Piaggi P; Thearle MS; Krakoff J; Votruba SB
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3011-20. PubMed ID: 26086330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic responses to intracerebroventricular leptin and restricted feeding.
    Wang T; Hartzell DL; Rose BS; Flatt WP; Hulsey MG; Menon NK; Makula RA; Baile CA
    Physiol Behav; 1999 Jan 1-15; 65(4-5):839-48. PubMed ID: 10073490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of kappa opioid receptor antagonism on energy expenditure in the obese Zucker rat.
    Jarosz PA
    Biol Res Nurs; 2007 Apr; 8(4):294-9. PubMed ID: 17456590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Energy expenditure and substrate oxidation rates of obese rats during a 12-day treatment with dexfenfluramine.
    Boschmann M; Aust L; Frenz U; Noack R
    Ann Nutr Metab; 1996; 40(1):10-23. PubMed ID: 8722302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energy metabolism and expression of uncoupling proteins 1, 2, and 3 after 21 days of recovery from intracerebroventricular mouse leptin in rats.
    Gullicksen PS; Flatt WP; Dean RG; Hartzell DL; Baile CA
    Physiol Behav; 2002 Apr; 75(4):473-82. PubMed ID: 12062312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamine enantiomers and rat consummatory behavior: a new perspective.
    Nichols MB; Maickel RP
    Pharmacol Biochem Behav; 1989 May; 33(1):181-8. PubMed ID: 2780775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary modulation of the anorectic potency of amphetamine.
    Marks-Kaufman R; Kanarek RB
    Pharmacol Biochem Behav; 1990 Feb; 35(2):301-6. PubMed ID: 2320637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between metabolic and behavioral effects of dexfenfluramine treatment.
    Even P; Coulaud H; Aucouturier JL; Nicolaidis S
    Clin Neuropharmacol; 1988; 11 Suppl 1():S93-6. PubMed ID: 3180112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of amphetamine on human macronutrient intake.
    Foltin RW; Kelly TH; Fischman MW
    Physiol Behav; 1995 Nov; 58(5):899-907. PubMed ID: 8577886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel antiobesic HMR1426 reduces food intake without affecting energy expenditure in rats.
    Ortmann S; Kampe J; Gossel M; Bickel M; Geisen K; Jähne G; Lang HJ; Klaus S
    Obes Res; 2004 Aug; 12(8):1290-7. PubMed ID: 15340112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dextrofenfluramine increases energy cost of muscular effort.
    Even P; Nicolaidis S
    Pharmacol Biochem Behav; 1986 Mar; 24(3):647-55. PubMed ID: 3703900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the alpha 2-adrenoceptor agonist, guanfacin, on energy expenditure, intake and deposition in rats.
    Gazzola C
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1995 Sep; 112(1):29-34. PubMed ID: 8564787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic fenfluramine treatment: effects on body weight, food intake and energy expenditure.
    Stallone DD; Levitsky DA
    Int J Obes Relat Metab Disord; 1994 Oct; 18(10):679-85. PubMed ID: 7866463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats.
    Larsen PJ; Fledelius C; Knudsen LB; Tang-Christensen M
    Diabetes; 2001 Nov; 50(11):2530-9. PubMed ID: 11679431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic studies in rats under glucose and glycerol loading.
    Om P; Hohenegger M
    Int J Vitam Nutr Res; 1979; 49(3):317-21. PubMed ID: 528159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of the effect of amphetamine on eating is biphasic.
    Jones JR; Caul WF
    Behav Neurosci; 1989 Oct; 103(5):1047-52. PubMed ID: 2803552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.